CUAMC
CRNX icon

China Universal Asset Management Company’s Crinetics Pharmaceuticals CRNX Stock Holding History

China Universal Asset Management Company’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$688K Sell
18,381
-200
-1% -$7.43K 0.04% 239
2026
Q1 		$675K Buy
18,581
+3,118
+20% +$139K 0.05% 237
2025
Q4 		$720K Sell
15,463
-1,045
-6% -$46.5K 0.06% 217
2025
Q3 		$688K Sell
16,508
-2,307
-12% -$73.8K 0.06% 212
2025
Q2 		$541K Buy
18,815
+151
+0.8% +$4.66K 0.05% 234
2025
Q1 		$626K Sell
18,664
-1,000
-5% -$37.3K 0.06% 225
2024
Q4 		$1.01M Buy
19,664
+4,271
+28% +$239K 0.09% 161
2024
Q3 		$787K Buy
15,393
+6,128
+66% +$316K 0.09% 162
2024
Q2 		$415K Sell
9,265
-4,099
-31% -$189K 0.06% 162
2024
Q1 		$626K Buy
13,364
+5,643
+73% +$221K 0.08% 166
2023
Q4 		$275K Buy
7,721
+6,318
+450% +$194K 0.05% 180
2023
Q3 		$41.7K Buy
1,403
+695
+98% +$14.3K 0.01% 240
2023
Q2 		$12.8K Sell
708
-23
-3% -$459 ﹤0.01% 304
2023
Q1 		$11.7K Buy
731
+184
+34% +$3.4K ﹤0.01% 271
2022
Q4 		$10K Buy
547
+44
+9% +$775 ﹤0.01% 226
2022
Q3 		$10K Buy
+503
New +$10.3K ﹤0.01% 204

Other funds holding CRNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

China Universal Asset Management Company's CRNX Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Crinetics Pharmaceuticals (CRNX) stake by 1.1% in Q2 2026, selling an estimated $7.43K and leaving 18,381 shares worth $688K. The position accounts for 0.04% of the portfolio, ranked #239.

China Universal Asset Management Company first reported a position in CRNX in Q3 2022 and has held it in 16 quarters since. The position peaked at $1.01M in Q4 2024. 183 funds tracked by Wall St. Rank hold CRNX as of Q2 2026.

  • China Universal Asset Management Company held 18,381 shares of Crinetics Pharmaceuticals worth $688K as of Q2 2026.
  • China Universal Asset Management Company sold 200 Crinetics Pharmaceuticals shares in Q2 2026, an estimated $7.43K.
  • Crinetics Pharmaceuticals made up 0.04% of China Universal Asset Management Company's portfolio in Q2 2026, its #239 holding.
  • China Universal Asset Management Company first reported a position in Crinetics Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
  • China Universal Asset Management Company's Crinetics Pharmaceuticals position peaked at $1.01M in Q4 2024.
  • 183 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.